Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.16% Nasdaq Up0.13%

Response Genetics, Inc (RGDX)

-NasdaqCM

1.38 Down 0.05(3.49%) 11:30AM EDT - Nasdaq Real Time Price

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Sep 29, 2012Jun 29, 2012Mar 30, 2012
Total Revenue 5,516   5,404   3,835   3,982  
Cost of Revenue2,520  2,769  2,426  2,701  
Gross Profit 2,996   2,635   1,409   1,281  
Operating Expenses
Research Development433  426  700  570  
Selling General and Administrative3,018  3,604  3,416  3,812  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (454) (1,395) (2,707) (3,101)
Income from Continuing Operations
Total Other Income/Expenses Net(14)0  0  0  
Earnings Before Interest And Taxes(468)(1,395)(2,707)(3,101)
Interest Expense19  20  23  23  
Income Before Tax(487)(1,415)(2,730)(3,125)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(487)(1,415)(2,730)(3,125)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (487) (1,415) (2,730) (3,125)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (487) (1,415) (2,730) (3,125)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.